Peter Salzmann - 03 Aug 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Executive Officer, Director
Signature
/s/ Pamela Yanchik Connealy, attorney-in-fact for Peter Salzmann
Issuer symbol
IMVT
Transactions as of
03 Aug 2021
Net transactions value
$0
Form type
4
Filing time
04 Aug 2021, 16:06:02 UTC
Previous filing
17 Jun 2021
Next filing
14 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +570,613 +431% $0.000000 703,113 03 Aug 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 37.5% of the RSUs will vest on January 1, 2022 and the remainder of the RSUs will vest on August 3, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date.